Virulence Plasmid Gives Drug-Resistant SuperbugClone a Decisive Fitness Edge

One of the world’s most alarming drug-resistant pathogens is winning its global expansion through a single molecular weapon, according to a new genomic study published in International Microbiology. Researchers led by Yalu Ren of the First Affiliated Hospital of Soochow University analyzed 43,722 Klebsiella pneumoniae genomes collected from 112 countries between 2011 and 2022, and found that the ST11-KL64 subclone of carbapenem-resistant K. pneumoniae has surged to dominance because it holds onto the pLVPK virulence plasmid far more reliably than its closest rival, the ST11-KL47 subclone. That stability allows the bacteria to combine near-untreatable carbapenem resistance with the destructive virulence toolkit of hypervirulent strains, producing organisms that can both survive antibiotic pressure and cause severe, invasive disease.

Klebsiella pneumoniae has long been divided into two epidemiological personalities. Classical strains colonize hospitals, infecting newborns, elderly patients and the immunocompromised, and are a leading cause of hospital-acquired infections and neonatal septicemia. Hypervirulent strains, by contrast, strike healthy people in the community, causing devastating syndromes such as pyogenic liver abscess, endophthalmitis and meningitis. For years these two worlds barely overlapped: hospital strains were resistant but relatively tame, while community strains were virulent but broadly susceptible to antibiotics. The US Centers for Disease Control and Prevention and the World Health Organization have both flagged carbapenem-resistant K. pneumoniae, or CRKP, as one of the most urgent threats in medicine, with new antimicrobials desperately needed.

That tidy separation collapsed in 2016, when strains of the ST11 lineage began acquiring pLVPK-like virulence plasmids, the mobile genetic elements that carry the genes behind hypervirulence. The resulting carbapenem-resistant hypervirulent K. pneumoniae, or CR-hvKP, fuses the worst features of both worlds. A fatal hospital outbreak in China described in 2018 first sounded the alarm, and the new study now provides a global, decade-scale accounting of what happened next. Within the ST11 lineage, two capsular subtypes, KL64 and KL47, emerged as the principal vehicles of CRKP, and their fortunes diverged dramatically.

The data show that KL47 was the dominant subtype from 2011 to 2015, after which its numbers plateaued. KL64, by contrast, entered a phase of explosive growth beginning in 2016 and overtook KL47 to become China’s predominant CRKP subtype, accounting for 40.5 percent of ST11-CRKP strains versus 28.9 percent for KL47. Regional patterns were stark: KL64 dominated Zhejiang province with 62.3 percent of strains and Sichuan with 58.7 percent, while KL47 held sway in Beijing, Jiangsu and Anhui. Globally, the picture was equally uneven, with KL24 dominant in Spain, Poland, Russia and Pakistan, KL105 predominant in the United Kingdom, and KL64 leading in Brazil and Uruguay. Of the ST11-CRKP strains examined, 89.7 percent carried carbapenemase genes, most commonly KPC-2 at 77.8 percent, followed by OXA-48 and NDM-1.

The decisive difference between the two subclones lay in how faithfully they maintained the virulence plasmid. Among 2,390 KL64 isolates, 60.5 percent carried the aerobactin gene, a key iron-scavenging virulence factor typically housed on pLVPK-like plasmids, compared with just 27.3 percent of 1,706 KL47 isolates. Detection of the RmpADC genes, which enhance capsular expression, showed an even wider gap: 40.7 percent in KL64 against 2.1 percent in KL47. The trajectory of aerobactin carriage tracked KL64’s rise almost perfectly. From 2015 to 2020, aerobactin-positive KL64 strains climbed from 58.9 percent to 86.6 percent of that subclone, while KL47’s aerobactin rate stayed flat in single digits. Patients infected with aerobactin-carrying strains faced significantly worse outcomes, with an odds ratio of 2.34 for severe disease.

Complete genome sequencing of 125 KL64 and 87 KL47 isolates exposed the molecular mechanism. Among aerobactin-positive strains, 98.7 percent of KL64 carried the gene on a plasmid, and 94.8 percent of those plasmids were intact and highly similar to the canonical pLVPK plasmid. In KL47, by contrast, only 41.2 percent of plasmids were intact; 58.8 percent had fused with IncFIB(pNDM-Mar)-like plasmids, leaving behind truncated remnants retaining little more than aerobactin and tellurium-resistance genes, and 41.4 percent of KL47 strains had lost the plasmid entirely, with virulence genes scattered onto the chromosome. Genome-wide comparison confirmed the disparity in gene retention: 71.2 percent of KL64 plasmids preserved the bulk of pLVPK genes, while most KL47 plasmids showed deletions exceeding 30 percent of the reference genome, with half losing more than 45 percent.

The fusion events themselves revealed a fascinating evolutionary intermediate. Twelve of fourteen truncated plasmids arose when pLVPK recombined with IncFIB(pNDM-Mar), a replicon type so rare it appeared almost exclusively in these hybrids. In thirteen strains, the recombination went further: genes from both parent plasmids, including aerobactin and type IV secretion system components, were transferred into the chromosome at a highly conserved insertion site marked by IS26 sequences. These chromosomal integrations appeared in hospitals across multiple regions, hinting that the instability of pLVPK in the KL47 background pushes the plasmid toward destructive recombination, while the KL64 genomic environment accommodates it intact. The researchers suggest this reflects classic plasmid fitness economics: acquiring a large virulence plasmid imposes metabolic costs that vary with host background, and KL47 appears to resolve those costs by shedding or chopping up the plasmid, whereas KL64 tolerates it stably enough to reap the full virulence benefit.

Geography and ecology help explain why ST11, rather than its American counterpart ST258, became the CR-hvKP powerhouse. Only 15 of 3,726 ST258-CRKP strains, a mere 0.4 percent, had acquired pLVPK-like plasmids, versus 33.9 percent of ST11-CRKP strains. The likely reason is proximity: hypervirulent KL1 and KL2 strains, the natural reservoirs of pLVPK, are concentrated in Asia, where intestinal colonization rates of K. pneumoniae in healthy Chinese adults reach 62.1 percent. In China, 48.4 percent of ST11-CRKP strains carry pLVPK-like plasmids, while in the United States only 0.5 percent of ST258-CRKP strains do. Intensive care units appear to be critical mixing vessels. In Sichuan, only 7.7 percent of human ST11-CRKP strains had acquired pLVPK-like plasmids, but 40 percent of environmental strains from neuro-intensive care and respiratory ICU surfaces had, underscoring the role of hospital environments in catalyzing plasmid transfer.

The evolutionary stakes are high. Strains carrying pLVPK-like plasmids survive environmental stress better, establish intestinal colonization more effectively and are associated with higher mortality than ordinary CRKP infections, and the loss of pLVPK sharply reduces extraintestinal spread. The authors acknowledge limitations, including geographic sampling bias toward well-resourced Chinese provinces and reduced data availability after 2020 due to sequencing submission lag. Even so, the message for surveillance is unambiguous. Monitoring plasmid-mediated virulence, not just resistance genes, may be essential to anticipate which CRKP clones will explode next, particularly in critical care settings where horizontal gene transfer can rewrite a pathogen’s arsenal within a single hospital ward. As the ST11-KL64 story demonstrates, in the arms race between antibiotics and bacteria, the plasmid is the engine of conquest.

Subject of Research: Plasmid-mediated fitness advantages underlying the global spread of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-KL64.

Article Title: A fitness advantage from the pLVPK plasmid fuels the global spread of a carbapenem-resistant hypervirulent Klebsiella pneumoniae high-risk clone: ST11-KL64

Article References: Ren, Y., Li, X., Ju, L., Yao, Y., Chen, X., & Wang, X. (2026). A fitness advantage from the pLVPK plasmid fuels the global spread of a carbapenem-resistant hypervirulent Klebsiella pneumoniae high-risk clone: ST11-KL64. International Microbiology. https://doi.org/10.1007/s10123-026-00888-z

Image Credits: AI Generated

DOI: 10.1007/s10123-026-00888-z

Keywords: Klebsiella pneumoniae, pLVPK plasmid, carbapenem resistance, hypervirulence, ST11-KL64, aerobactin, genomic surveillance, horizontal gene transfer, CR-hvKP, plasmid stability, antimicrobial resistance, public health